- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04330482
Translating a Dementia Caregiver Intervention Into a Mobile Application
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Caring for a person with dementia is a highly stressful activity and is associated with negative physical and mental health consequences, including increased risk of depression and worse reported health-related quality of life. The proposed project aims to develop and translate an evidence-based, multi-component intervention into a mHealth App that has the potential to increase dementia caregivers' access to support and care.
The investigators will conduct a feasibility trial, in which 40 dementia caregivers will be randomized to receive a computer tablet preloaded with the CARE-well App or preloaded with internet links relevant to dementia and caregiving. Paper outcome measures will be assessed at baseline and end of intervention (3 months) during each study visit. To measure sustainability of the App, the first 10 caregivers from each group will be offered the tablets for an additional month to monitor usage of the App outside the formal trial. The goal of this aim is to determine feasibility of the intervention, study procedures, and outcome measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Kingston, Rhode Island, United States, 02881
- University of Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adequate English-speaking and reading skills
- Provide at least 4 hours of supervision per day for the care recipient (either directly or by telephone)
- Live in the community (either with the care recipient or without)
- Have provided supervision/ assistance for at least 6 months prior to study enrollment and have no plans to place care recipient in long term care or to end their role as caregiver within 6 months of study enrollment.
- Report some degree of distress associated with caregiving
- Access to Wifi at home
Exclusion Criteria:
- Major acute medical illness
- Severe mental illness (e.g. bipolar, schizophrenia)
- Diagnosed cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Internet Links
A tablet pre-loaded with a list of internet links relating to dementia caregiving that participants will be instructed to use at least 4 times weekly for 3 months.
|
Participants randomized into this group will be instructed to use a computer tablet pre-loaded with a list of internet links relevant to dementia caregiving at least 4 times per week.
|
Experimental: CARE-Well App
A tablet pre-loaded with the CARE-Well app that participants will be instructed to use at least 4 times weekly for 3 months.
|
Participants randomized into this group will be instructed to use the CARE-Well App at least 4 times per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Randomization
Time Frame: 3 months
|
Percentage of participants who decline participation because of randomization.
|
3 months
|
Completion Rates
Time Frame: 3 months
|
Percentage of participants who completed the intervention.
|
3 months
|
Interest in Continuation of Tablet/App Use After Formal Trial
Time Frame: 3 months
|
Percentage of participants in a subset of caregivers (10 from each group) interested in continuing to use tablet/App use after formal trial as an estimate of sustainability.
|
3 months
|
Study Enrollment Rate and Retention
Time Frame: 3 months
|
Percentage of participants enrolled and who remain enrolled for the duration of the study.
|
3 months
|
Intervention Adherence
Time Frame: 3 months
|
Percentage of participants who used the internet links or the app for the 3-month intervention period.
|
3 months
|
Timing of Assessments
Time Frame: 3 months
|
Percentage of participants who completed assessments at baseline and follow-up within two weeks of enrollment or completion of the study.
|
3 months
|
App Technology Satisfaction
Time Frame: 3 months
|
Percentage of participants satisfied or very satisfied with App technology.
|
3 months
|
App Content Satisfaction
Time Frame: 3 months
|
Percentage of participants satisfied or very satisfied with App content.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Center for Epidemiologic Studies Depression Scale
Time Frame: Baseline and immediately Post-Intervention at 3 months
|
Depression scale; 0-30 points; higher scores indicate worse outcome.
|
Baseline and immediately Post-Intervention at 3 months
|
Zarit Burden Interview
Time Frame: Baseline and immediately Post-Intervention at 3 months
|
Caregiver burden scale; 0-88 points; higher scores indicate worse outcome.
|
Baseline and immediately Post-Intervention at 3 months
|
Revised Memory and Behavior Problem Checklist
Time Frame: Baseline and immediately Post-Intervention at 3 months
|
Caregiver reaction to problem behaviors; range 0-96 Higher scores indicate worse outcomes.
|
Baseline and immediately Post-Intervention at 3 months
|
Desire to Institutionalize Scale
Time Frame: Baseline and immediately Post-Intervention at 3 months
|
Caregiver desire to institutionalize care recipient; 0-7 points; high scores indicate worse outcome (or stronger desire to institutionalize).
|
Baseline and immediately Post-Intervention at 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Geoffrey Tremont, PhD, Rhode Island Hospital
- Principal Investigator: Kunal Mankodiya, PhD, University of Rhode Island
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R21AG064410-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Internet Links
-
Abby LohrEl Rio Community Health Center; Pima County Health Department; Yuma County Health... and other collaboratorsCompleted
-
Colorado School of Public HealthNational Institute for Occupational Safety and Health (NIOSH/CDC)Completed
-
Jean EdwardCompletedFinancial Stress | Survivorship | Hematologic CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell NeoplasmUnited States
-
Oregon Social Learning CenterSan Diego State UniversityCompletedSchool Adjustment | Foster Care DisruptionsUnited States
-
Yale UniversityWithdrawnKnowledge Bases
-
Medical College of WisconsinNot yet recruiting
-
Medical College of WisconsinEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPremature Birth | Decision Making | Resuscitation | Infant, Premature | Prenatal CareUnited States
-
Northwestern UniversityRecruitingDepression | Anxiety | Suicidal IdeationUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States